The average price predicted for Aptevo Therapeutics Inc (APVO) by analysts is $8.38, which is $8.2 above the current market price. The public float for APVO is 11.40M, and at present, short sellers hold a 0.92% of that float. On November 13, 2023, the average trading volume of APVO was 445.92K share
StockNews.com started coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research note released on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners began coverage on shares of Aptevo Therapeutics in a research report on Monday, October 9th. They set a buy rating […]
Alliance Global Partners began coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a report released on Monday, FlyOnTheWall reports. The brokerage issued a buy rating on the biotechnology company’s stock. Separately, StockNews.com began coverage on Aptevo Therapeutics in a report on Monday. They set a hold rating on the stock. Get Our […]
StockNews.com started coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Aptevo Therapeutics Stock Up 5.8 % NASDAQ APVO opened at $0.32 on Monday. Aptevo Therapeutics has a 12 month low of $0.30 […]
President Emmerson Mnangagwa officially commenced the First Session of the 10th Parliament of Zimbabwe on Tuesday. In his address, he urged legislators to prior.